The PPD™ clinical research business of Thermo Fisher Scientific is a global contract research organization (CRO) delivering clinical expertise for your product's success. Learn more about our life changing therapies.

作为全球领先的cro公司，我们坚持扎根中国，并在中国拥有超过1,500位专业团队成员，且在持续扩展中。

PPD百时益作为一家知名外资CRO，似乎在业界低调许多，但其历史发展颇为传奇——由药学博士 Fred Eshelman 于1985年创立；1996年第一次IPO；2011年，PPD以 39 亿美元收购完成私有化；2020年，PPD在美国纳斯达克再度上市，融资16.2亿美元，成为当年规模最大的IPO。

The PPD™ clinical research business of Thermo Fisher Scientific is a leading provider of global CRO solutions. Leading the way in clinical research. We provide comprehensive drug development, laboratory and lifecycle services to customers across pharmaceutical, biotechnology, medical device, academic and government entities.

PPD clinical development and analytical services enable customers to accelerate innovation and increase drug development productivity.

3） PPD的招聘实在做得有点简单和粗糙尤其是在吸引点的描述和宣传方面，干巴巴就拿一个global CRO的名头去吸引人肯定要吃不少亏的，尽管本身能够提供的项目资源，培训和工资福利其实在外资CRO里面是靠前的。

最近几年外资大CRO经历过几次合并，收购，目前能叫得上名字的，也就是 IQVIA艾昆纬 （前昆泰）、 Fortrea富启睿 （前科文斯、徕博科）、 Parexel精鼎 、PPD百时益、ICON爱恩康（包含PRA）、Syneos赛纽仕（前INC和InVentiv Health合并）这六家了，其他几家如Novotech诺为泰 ...

PPD，全称：Pharmaceutical Product Development，中文名： 百时益. 他是真的低调，低调到很多人都不知道这家 Top CRO 的名字。不过也和它前几年在中国的业务并不多有关系。从19年开始，PPD才开始布局大范围进入中国市场，20年正式大举进入中国市场。

Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific .

Our Clinical Research team, who powers our PPD ® clinical research portfolio, are part of our leading global contract research organization (CRO). We provide comprehensive, integrated drug development, laboratory and lifecycle management services.